Protective effect of decorin on acute ischaemia-reperfusion injury in the rat kidney

Archives of Medical Science

Volumn 7, Issue 2, 2011, Pages 211-216

  Alan, Cabir ^a   Kocoglu, Hasan ^b   Altintas, Ramazan ^c   Alici, Bülent ^c   Ersay, Ahmet Resit ^a  

^a ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^b Canakkale Military Hospital   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Decorin; Glomerulosclerosis; Transforming growth factor 1

Indexed keywords

EID: 79956353613     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.22069     Document Type: Article

References (39)

1. Kalman S. Cytokins and growth factors in renal injury. J Turk Soc Nephrol 2002; 11: 140-3.
2. Mozes MM, Böttinger EP, Jacot TA. Renal expression of fibrotic matrix proteins and of transforming growth factorbeta1 (TGF-beta1) isoforms in TGF-beta1 transgenic mice. J Am Soc Nephrol 1999; 10: 271-80. (Pubitemid 29068066)
3. Border WA, Okuda S, Languino LR. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta1. Nature 1990; 346: 371-4.
4. Border W, Noble N. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 11: 1286-92. (Pubitemid 24333194)
5. Xing Z, Tremblay G, Gauldie PJ. Overexpression of GM-CSF induces pulmonary granulation tissue formation and fibrosis by induction of TGFbeta1 and myofibroblast accumulation. Am J Pathol 1997; 150: 59-66. (Pubitemid 27027096)
6. Xing Z, Jordana M, Gauldie J. Cytokines and pulmonary inflammatory and immune diseases. Histol Histopathol 1999; 14: 185-201. (Pubitemid 29049367)
7. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta1 by the proteoglycan decorin. Nature 1990; 346: 281-4.
8. Isaka Y, Brees DK, Ikegaya K. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996; 12: 418-23. (Pubitemid 26191913)
9. Patel S, Santra M, McQuillan DJ. Decorin activates the epidermal growth factor receptor and elevates cytosolic Ca2+ in A431 carcinoma cells. J Biol Chem 1998; 273: 3121-4. (Pubitemid 28109714)
10. Fischer JW, Kinsella MG, Clowes MM. Local expression of bovine decorin by cell-mediated gene transfer reduces neointimal formation after baloon injury in rats. Circ Res 2000; 86: 676-83.
11. Giri SN, Hyde DM, Braun RK. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol 1997; 54: 1205-16. (Pubitemid 27497247)
12. Isaka Y, Brees DK, Ikegaya K. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996; 2: 418-23. (Pubitemid 26191913)
13. Kolb M, Margetts PJ, Galt T. Transient transgene expression of decorin in the lung reduces the fibrotic responce to bleomycin. Am J Respir Crit Care Med 2001; 163: 770-7. (Pubitemid 32230842)
14. Fridovich I. Superoxide radical: an endogenous toxicant. Ann Rev Pharmacol Toxicol 1983; 23: 239-57. (Pubitemid 13079375)
15. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbutiric acid reaction. Anal Biochem 1979; 95: 351-8. (Pubitemid 9194347)
16. Bi Y, Ehirchiou D, Kilts TM, et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007; 13: 1219-27. (Pubitemid 47530625)
17. Inkson CA, Ono M, Bi Y, Kuznetsov SA, Fisher LW, Young MF. The potential functional interaction of biglycan and WISP-1 in controlling differentiation and proliferation of osteogenic cells. Cells Tissues Organs 2009; 189: 153-7.
18. Hildebrand A, Romaris M, Rasmussen LM, et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 1994; 302: 527-34. (Pubitemid 24280108)
19. Nakajima M, Kizawa H, Saitoh M, Kou I, Miyazono K, Ikegawa S. Mechanisms for asporin function and regulation in articular cartilage. J Biol Chem 2007; 282: 32185-92. (Pubitemid 350106455)
20. Li X, McFarland DC, Velleman SG. Extracellular matrix proteoglycan decorin-mediated myogenic satellite cell responsiveness to transforming growth factor-beta1 during cell proliferation and differentiation Decorin and transforming growth factor-beta1 in satellite cells. Domest Anim Endocrinol 2008; 35: 263-73.
21. Comalada M, Cardo M, Xaus J, et al. Decorin reverses the repressive effect of autocrine-produced TGF-beta on mouse macrophage activation. J Immunol 2003; 170: 4450-6. (Pubitemid 36519949)
22. Bi Y, Stuelten CH, Kilts T, et al. Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J Biol Chem 2005; 280: 30481-9. (Pubitemid 41216232)
23. Defraigne JQ, Detry O, Pincemail J. Direct evidence of free radical production after ischemia and reperfusion and protective effect of desferrioxamine: ESR and vitamin E studies. Eur J Vasc Surg 1994; 8: 537-43. (Pubitemid 24270154)
24. Bird JE, Milhoan K, Wilson CB. Ischemic acute renal failure and antioxidant therapy in the rat: the relaxation between glomerular and tubular dysfunction. J Clin Invest 1988; 81: 1630-8.
25. Paller MS, Hoidal JR, Ferris TF. Oxygen free radical in ischemic acute renal failure in the rat. J Clin Invest 1984; 74: 1156-64. (Pubitemid 15206810)
26. Bonventre JV. Mechanism of ischemic acute renal failure. Kidney Int 1993; 43: 1160-78. (Pubitemid 23137105)
27. Rhoden EL, Rhoden CR, Mauri M. Experimental model of renal ischemia-reperfusion in rats: study of the stress oxidative induced by oxygen-derived free radicals. J Urol 1999; 25: 431-5.
28. Li PF, Dietz R, Harsdorf RV. Superoxide induces apoptosis in cardiomyocytes, but proliferation and expression of transforming growth factor-beta1 1 in cardiac fibroblasts. FEBS Letters 1999; 448: 206-10. (Pubitemid 29168489)
29. Fukui N, Fukuda A, Kojima K. Suppression of fibrous adhesion by proteoglycan decorin. J Orthop Res 2001; 19: 456-62. (Pubitemid 32472017)
30. Border W, Noble N. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331: 1286-92. (Pubitemid 24333194)
31. Vogel KG, Paulsson M, Heinegard D. Specific inhibition of type I and II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 1984; 223: 587-97. (Pubitemid 15209051)
32. Winnemoller M, Schmidt G, Kresse H. Influence of decorin on fibroblast adhesion to fibronectin. Eur J Cell Biol 1991; 54: 10-7.
33. Winnemoller M, Schon P, Vischer P. Interactions between thrombospondin and the small proteoglycan decorin: Interference with cell attachment. Eur J Cell Biol 1992; 59: 47-55.
34. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta1 by the proteoglycan decorin. Nature 1990; 346: 281-4.
35. Isaka Y, Brees DK, Ikegaya K. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996; 2: 418-23. (Pubitemid 26191913)
36. Patel S, Santra M, McQuillan DJ. Decorin activates the epidermal growth factor receptor and elevates cytosolic Ca2+ in A431 carcinoma cells. J Biol Chem 1998; 273: 3121-4. (Pubitemid 28109714)
37. Hideo M, Yoshinobu T, Mitsuru H. Pharmacokinetics and disposition characteristics of recombinant decorin after intravenous injection into mice. Biochim Biophys Acta 1999; 1426: 420-8.
38. Rhoden EL, Rhoden CR, Lucas ML. The role of nitric oxide pathway in the renal ischemia-reperfusion injury in rats. Trans Immunol 2002; 10: 277-84. (Pubitemid 35439197)
39. Schaefer L, Macakova K, Raslik I. Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol 2002; 160: 1181-91. (Pubitemid 34224603)